{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:46:34Z","timestamp":1783651594942,"version":"3.55.0"},"reference-count":44,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/mmr.2017.6318","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T09:17:24Z","timestamp":1489483044000},"page":"2574-2582","source":"Crossref","is-referenced-by-count":38,"title":["Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT\/ANP\/BNP signaling pathway"],"prefix":"10.3892","volume":"15","author":[{"given":"Xiurong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuai","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eryang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"key20180108015137_b1-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM199210013271406","article-title":"The heart in hypertension","volume":"327","author":"Frohlich","year":"1992","journal-title":"N Engl J Med"},{"key":"key20180108015137_b2-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.CIR.58.5.763","article-title":"Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure","volume":"58","author":"Curtiss","year":"1978","journal-title":"Circulation"},{"key":"key20180108015137_b3-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2165\/00003495-199856060-00007","article-title":"Telmisartan","volume":"56","author":"McClellan","year":"1998","journal-title":"Drugs"},{"key":"key20180108015137_b4-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1476-5381.1993.tb13800.x","article-title":"Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277","volume":"110","author":"Wienen","year":"1993","journal-title":"Br J Pharmacol"},{"key":"key20180108015137_b5-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/147323000203000601","article-title":"ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension","volume":"30","author":"Amerena","year":"2002","journal-title":"J Int Med Res"},{"key":"key20180108015137_b6-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/0253-7613.81489","article-title":"Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension","volume":"43","author":"Saha","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"key20180108015137_b7-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1291\/hypres.28.555","article-title":"Telmisartan Study Group: Telmisartan\/Hydrochlorothiazide in comparison with losartan\/hydrochlorothiazide in managing patients with mild-to-moderate hypertension","volume":"28","author":"Neutel","year":"2005","journal-title":"Hypertens Res"},{"key":"key20180108015137_b8-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004872-199402000-00003","article-title":"Effects on binding characteristics and renal function of the novel, non-peptide angiotensin II antagonist BIBR277 in the rat","volume":"12","author":"Wienen","year":"1994","journal-title":"J Hypertens"},{"key":"key20180108015137_b9-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/dc06-1998","article-title":"INNOVATION Study Group: Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes","volume":"30","author":"Makino","year":"2007","journal-title":"Diabetes Care"},{"key":"key20180108015137_b10-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1291\/hypres.27.457","article-title":"Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: A randomized, double-blind, placebo-controlled 12-month study","volume":"27","author":"Derosa","year":"2004","journal-title":"Hypertens Res"},{"key":"key20180108015137_b11-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2337\/diacare.28.2.498","article-title":"Possible beneficial effect of telmisartan on glycemic control in diabetic subjects","volume":"28","author":"Honjo","year":"2005","journal-title":"Diabetes Care"},{"key":"key20180108015137_b12-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.metabol.2006.04.011","article-title":"The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects","volume":"55","author":"Nagel","year":"2006","journal-title":"Metabolism"},{"key":"key20180108015137_b13-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(24)29352-6","article-title":"AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats","volume":"298","author":"Gohlke","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180108015137_b14-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2008.08.032","article-title":"Telmisartan prevented cognitive decline partly due to PPAR-gamma activation","volume":"375","author":"Mogi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108015137_b15-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00408661","article-title":"Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade","volume":"163\u2013164","author":"B\u00f6hm","year":"1996","journal-title":"Mol Cell Biochem"},{"key":"key20180108015137_b16-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijcard.2003.10.018","article-title":"Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan","volume":"97","author":"Mattioli","year":"2004","journal-title":"Int J Cardiol"},{"key":"key20180108015137_b17-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/labinvest.2011.45","article-title":"Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma","volume":"91","author":"Maejima","year":"2011","journal-title":"Lab Invest"},{"key":"key20180108015137_b18-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9149(99)00727-4","article-title":"Angiotensin II receptor blockers: Review of the binding characteristics","volume":"84","author":"Siragy","year":"1999","journal-title":"Am J Cardiol"},{"key":"key20180108015137_b19-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ehjci\/jev155","article-title":"Right ventricular remodelling induced by exercise training in competitive athletes","volume":"17","author":"D'Ascenzi","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"key20180108015137_b20-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol Ther"},{"key":"key20180108015137_b21-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180108015137_b22-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1084\/jem.20090872","article-title":"The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia","volume":"206","author":"Irani","year":"2009","journal-title":"J Exp Med"},{"key":"key20180108015137_b23-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","article-title":"Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy","volume":"88","author":"Rockman","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108015137_b24-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5507\/bp.2001.011","article-title":"Neonatal rat cardiomyocytes-a model for the study of morphological, biochemical and electrophysiological characteristics of the heart","volume":"145","author":"Chlopc\u00edkov\u00e1","year":"2001","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"key20180108015137_b25-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108015137_b26-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc Res"},{"key":"key20180108015137_b27-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/01.RES.0000069211.82346.46","article-title":"NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro","volume":"92","author":"Pu","year":"2003","journal-title":"Circ Res"},{"key":"key20180108015137_b28-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1161\/CIRCULATIONAHA.104.510594","article-title":"Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides","volume":"111","author":"Tokudome","year":"2005","journal-title":"Circulation"},{"key":"key20180108015137_b29-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.HYP.35.1.188","article-title":"Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase","volume":"35","author":"Liang","year":"2000","journal-title":"Hypertension"},{"key":"key20180108015137_b30-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"14860","DOI":"10.1074\/jbc.272.23.14860","article-title":"Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes","volume":"272","author":"Wu","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180108015137_b31-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.ATV.19.1.140","article-title":"Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism","volume":"19","author":"Suenobu","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108015137_b32-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"H1635","DOI":"10.1152\/ajpheart.00984.2001","article-title":"Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension","volume":"282","author":"Diep","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20180108015137_b33-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ"},{"key":"key20180108015137_b34-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"key20180108015137_b35-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nat Cell Biol"},{"key":"key20180108015137_b36-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/hr.2010.182","article-title":"Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice","volume":"33","author":"Li","year":"2010","journal-title":"Hypertens Res"},{"key":"key20180108015137_b37-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5372\/1905-7415.0504.060","article-title":"Effects of telmisartan on angiotensin II-induced cardiomyocyte hypertrophy and p-ERK1\/2 phosphorylation in rat cultured cardiomyocytes","volume":"5","author":"Chang","year":"2011","journal-title":"Asian Biomed"},{"key":"key20180108015137_b38-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1074248411434773","article-title":"Ramipril and telmisartan exhibit differential effects in cardiac pressure overload-induced hypertrophy without an additional benefit of the combination of both drugs","volume":"18","author":"Muller","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"key20180108015137_b39-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","article-title":"Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy","volume":"94","author":"Wilkins","year":"2004","journal-title":"Circ Res"},{"key":"key20180108015137_b40-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.25.3.865-878.2005","article-title":"Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1\/2 signaling pathways regulate cardiac gene expression and cellular growth","volume":"25","author":"Sanna","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key20180108015137_b41-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.bbamcr.2013.04.003","article-title":"The transcription factor NFAT1 induces apoptosis through cooperation with Ras\/Raf\/MEK\/ERK pathway and upregulation of TNF-\u03b1 expression","volume":"1833","author":"Robbs","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key20180108015137_b42-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mehy.2004.09.015","article-title":"Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property","volume":"64","author":"Yamagishi","year":"2005","journal-title":"Med Hypotheses"},{"key":"key20180108015137_b43-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-008-9848-8","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin\/NFAT signaling pathway","volume":"317","author":"Bao","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"key20180108015137_b44-mmr-15-05-2574","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2017.6318\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T20:06:17Z","timestamp":1750104377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,14]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/mmr.2017.6318"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6318","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}